Lymphokine-Activated Killer Cells in Mouse Bone Marrow Chimaeras The Relationship to Natural Killer Cells and to Alloreactive Cytotoxic T Cells
- 31 October 1985
- journal article
- research article
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 22 (5) , 479-488
- https://doi.org/10.1111/j.1365-3083.1985.tb01906.x
Abstract
Spleen cells from mouse bone marrow chimaeras were cultured in vitro in mixed lymphocyte cultures (MLC) or in the presence of interleukin 2 (IL-2) without the added alloantigen. Precursors for the nonspecific cytotoxic cells (in this study: lymphokine-activated killer (LAK) cells) lysing natural killer (NK) cell-sensitive YAC-1 lymphoma could be found 10-12 days after the bone marrow reconstitution, simultaneously with the appearance of the NK activity. The ability of LAK cells to lyse NK-resistant tumour targets as well was demonstrated using the P 815 mastocytoma cell line; reactivity against this target was demonstrable 1 week later than the appearance of YAC-1 lysing cells. Phenotypically LAK cells derived from spleen cell cultures of bone marrow chimaeras did not differ from LAK cells derived from normal spleen cell cultures: precursors resided within the Thy 1-, asialo-GM1-cell population, and effectors expressed both of these antigens. Splenic NK cells of early bone marrow chimaeras (up to 14-18 days after the bone marrow reconstitution) were Thy 1- cells, and thus LAK cells of bone marrow chimaeras were not derived from these Thy1- NK cells. The treatment of effector cells with anti-Thy 1 antibody plus complement (C) abolished the lytic activity totally. However, these cells were not cytotoxic T cells, since alloreactivity, as an indication of the T-cell cytotoxicity, could not be demonstrated until 4-5 weeks after the bone marrow reconstitution.This publication has 22 references indexed in Scilit:
- High expression of the Thy-1 antigen on natural killer cells recently derived from bone marrowCellular Immunology, 1984
- Generation of nonspecific murine cytotoxic T cells in vitro by purified human interleukin 2Cellular Immunology, 1984
- Supplement-induced cytotoxic cells (SICC) generated from mouse thymus or spleen cells cultured in the presence of interleukin 2 and/or polyinosinic acidCellular Immunology, 1983
- Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells.The Journal of Experimental Medicine, 1983
- Reversible induction of natural killer cell activity in cloned murine cytotoxic T lymphocytesNature, 1983
- "Anomalous" THY-1(+) killer cells in allogeneic and F1-anti-parental mixed leukocyte culture. Relation to natural killer cells and allospecific cytotoxic T lymphocytesThe Journal of Experimental Medicine, 1982
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982
- On the heterogeneity of murine natural killer cells.The Journal of Experimental Medicine, 1981
- Xenogeneic serum-induced murine cytotoxic cellsCellular Immunology, 1979
- Tumor necrosis serum induces a serologically distinct population of NK cells.The Journal of Experimental Medicine, 1979